Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3735717017 | Temsirolimus only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3735718010 | Product containing only temsirolimus (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2861851000001115 | Temsirolimus (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2861861000001117 | Temsirolimus | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Temsirolimus | Has active ingredient | Temsirolimus | true | Inferred relationship | Existential restriction modifier | 1 | |
| Temsirolimus | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Temsirolimus | Is a | Product containing temsirolimus | true | Inferred relationship | Existential restriction modifier | ||
| Temsirolimus | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Temsirolimus | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Temsirolimus 30mg/1.2ml solution for infusion vials and diluent | Is a | True | Temsirolimus | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR